Ortho Clinical Diagnostics Holdings plc·4

Jan 5, 4:23 PM ET

Schlesinger Michael A. 4

4 · Ortho Clinical Diagnostics Holdings plc · Filed Jan 5, 2022

Insider Transaction Report

Form 4
Period: 2022-01-03
Schlesinger Michael A.
EVP, GC and Secretary
Transactions
  • Exercise/Conversion

    Ordinary Shares, $0.00001 par value

    2022-01-03$6.28/sh+130,000$816,400217,637 total
  • Exercise/Conversion

    Stock Option

    2022-01-03130,00088,043 total
    Exercise: $6.28Exp: 2024-10-22Ordinary Shares, $0.00001 par value (130,000 underlying)
  • Sale

    Ordinary Shares, $0.00001 par value

    2022-01-03$21.09/sh130,000$2,741,62287,637 total
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
  • [F3]Represents the weighted average sales price for the price increments ranging from $21.0000 to $21.2400.
  • [F4]The stock option is fully vested and exercisable.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION